Description

Minimally invasive endovascular embolization procedures decrease surgery time, speed up recovery, and provide the possibility for more comprehensive treatment of aneurysms, arteriovenous malformations (AVMs), and hypervascular tumors. Liquid embolic agents

Minimally invasive endovascular embolization procedures decrease surgery time, speed up recovery, and provide the possibility for more comprehensive treatment of aneurysms, arteriovenous malformations (AVMs), and hypervascular tumors. Liquid embolic agents (LEAs) are preferred over mechanical embolic agents, such as coils, because they achieve homogeneous filling of aneurysms and more complex angioarchitectures. The gold standard of commercially available LEAs is dissolved in dimethyl sulfoxide (DMSO), which has been associated with vasospasm and angiotoxicity.

1.61 MB application/pdf

Download count: 0

Details

Contributors
Date Created
  • 2019
Resource Type
  • Text
  • Collections this item is in
    Note
    • Partial requirement for: M.S., Arizona State University, 2019
      Note type
      thesis
    • Includes bibliographical references (pages 46-54)
      Note type
      bibliography
    • Field of study: Biomedical Engineering

    Citation and reuse

    Statement of Responsibility

    by Karime Jocelyn Rosas Gomez

    Machine-readable links